Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Trigger Finger Disorder 1Skin Neoplasms 1Rectal Neoplasms 1Pain, Postoperative 1Median Neuropathy 1Ileus 1Ganglion Cysts 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1De Quervain Disease 1Constipation 1Colonic Neoplasms 1Agnosia 1

Interventions

Sirolimus 3aldesleukin 2Tacrolimus 2Cyclosporine 2relatlimab 1oxycodone-acetaminophen 1abobotulinumtoxinA 1Vemurafenib 1Sodium Chloride 1Prednisone 1Nivolumab 1Mycophenolic Acid 1Meloxicam 1Ipilimumab 1Interleukins 1Interleukin-2 1Fluorouracil 1Everolimus 1Bleomycin 1Azathioprine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Skin Neoplasms × oxycodone-acetaminophen × Clear all
NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Baylor Research Institute

Phase 4 Enrolling by invitation
75 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡